Valens Groworks Corp (VLNS)

2.49
-0.02(-0.80%)
  • Volume:
    494,124
  • Bid/Ask:
    2.49/2.51
  • Day's Range:
    2.47 - 2.63
  • Type:Equity
  • Market:Canada
  • ISIN:CA91914P1080
  • CUSIP:00091914P108

VLNS Overview

Prev. Close
2.51
Day's Range
2.47-2.63
Revenue
72.94M
Open
2.53
52 wk Range
1.44-4
EPS
-0.25
Volume
494,124
Market Cap
463.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
333,080
P/E Ratio
-
Beta
1.68
1-Year Change
27.69%
Shares Outstanding
186,262,164
Next Earnings Date
Oct. 20, 2021
What is your sentiment on Valens Groworks Corp?
or
Market is currently closed. Voting is open during market hours.

Valens Groworks Corp News

Valens Groworks Corp Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Buy
SummarySellStrong SellStrong SellStrong SellNeutral

Valens Groworks Corp Company Profile

Valens Groworks Corp Company Profile

Employees
0
Market
Canada

The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.

Read More
  • This just can't break the $3 mark!!
    0
    • Thoughts?
      1
      • is this even trading??
        0
        • 10 CAD, can be too much, but i'm definitely long with TP at 6
          0
          • do you guys think this could hit 10$ in 2021?
            0
            • do you guys think this could hit 10$ in 2021?
              0
              • finally i feel alive!!!
                0
                • any idea if this going up
                  0
                  • it has to reach and close the day at 2.20 otherwise there's no pie in the sky
                    0
                    • it is super oversold, should start to rise at least i hope so!
                      0
                      • lill rebound before collapsing more?
                        0
                        • looks like you were right
                          0
                      • This is going to tank on earnings just like labs!
                        0
                        • this looks like it's being abused before earnings
                          0
                          • Yup, huge drop on earnings.
                            0
                        • any thoughts guys? will it drop some more? or gain back the losses and some $?
                          0
                          • Riccardo Pezzani to be honest, Medipharm made me loose faith in the smaller players
                            0
                          • Melv Herv I'm afraid you're right.. just holding this one to see if the future shines.. Gave me good gains in short weekly trades in the past, now looks the oblivion!!
                            0
                          • Riccardo Pezzani idk if Valens is exposed as much to b2b sales, that's what failed for Medipharm and why they changing strategy.
                            0
                        • The only thing this company needs is volume. Currently too much supply of shares for the demand. Once the volume really increases especially with their low outstanding shares of 127M, this will skyrocket to another galaxy. That's all this company needs, everything else they are doing is absolutely stunning👌🏼 Just needs a little more popularity
                          0
                          • i wish i never heard of this stock
                            1
                            • why do you say that
                              0
                          • Nuance products are on shoppers!
                            0
                            • Great products &packaging and momentum to expand !
                              0
                              • true. I really don't get why is so underperforming. i'm in at 2.91..
                                1
                            • Valens is going to graduated lol
                              0
                              • Real nice. crweworld.com/article/news-provided-by-pr-newswire/1429523/the-valens-company-reports-record-financial-performance-in-the-fourth-quarter-and-fiscal-year-ended-november-30-2019-with-q4-adjusted-ebitda1-of-177-million
                                0
                                • Evan Soukas Do you think that a price target of 5$ is fair for this year?
                                  0
                                • Evan Soukas I mean if the high growth and profitability sustain, it seems possible.
                                  0
                                • Maybe.
                                  0
                              • I smell opportunity with 12mins left before close;)
                                1
                                • any thoughts guys?
                                  1
                                  • not enough ppl know about valens I'll keep buying what a monster
                                    0
                                    • 2.42 cad this week
                                      0
                                      • buy in the 2's cad
                                        0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.